| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $167.2M | +20.4% |
| Cost of Revenue | $35.1M | +19.0% |
| Gross Profit | $132.1M | +20.7% |
| R&D Expense | $16.6M | +10.2% |
| SG&A Expense | $33.8M | +8.6% |
| Operating Income | -$35.2M | +24.9% |
| Income Tax | $0 | — |
| Net Income | -$30.9M | +28.7% |
| EPS (Basic) | -$0.75 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.9M | +5.0% |
| Accounts Receivable | $27.5M | +25.1% |
| Inventory | $27.1M | +33.7% |
| Current Assets | $207.8M | -1.7% |
| Total Assets | $230.4M | +0.0% |
| Current Liabilities | $27.1M | +15.7% |
| Long-term Debt | $35.5M | -1.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.4M | +33.6% |
| Capital Expenditures | $10.5M | +34.6% |
| Investing Cash Flow | $12.6M | +121.1% |
| Financing Cash Flow | $2.0M | -97.8% |
| Free Cash Flow | -$22.9M | +13.5% |
| +33.6% |
| EPS (Diluted) | -$0.75 | +33.6% |
| Total Liabilities |
| $63.5M |
| +4.0% |
| Stockholders' Equity | $167.0M | -1.4% |